Podcast
Become a Member to Save
Highlights from the 13th C1-inhibtor Deficiency and Angioedema Workshop 2023
An update and discussion of the latest scientific findings related to bradykinin-mediated angioedema
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Takeda UK Ltd. at: AE.GBR-IRL@takeda.com
